Ahmad A. Obaid
Mecca, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Correction: Untargeted metabolomics reveals distinct biomarkers and metabolic alterations in familial and non-genetic hypercholesterolemia in Saudi patients.
Journal: Frontiers in medicine
Published: February 25, 2026
Mechanistic Evaluation of Chlorfenapyr-Induced Hepatotoxicity and the Mitigating Actions of Resveratrol-Loaded Chitosan Nanoparticles.
Journal: Journal of applied toxicology : JAT
Published: December 29, 2025
Astaxanthin-loaded chitosan nanoparticles attenuate chlorpyrifos-induced nephrotoxicity via activation of the Nrf2/HO-1 axis and suppression of oxidative, inflammatory, and apoptotic pathways.
Journal: Tissue & cell
Published: November 27, 2025
Untargeted metabolomics reveals distinct biomarkers and metabolic alterations in familial and non-genetic hypercholesterolemia in Saudi patients.
Journal: Frontiers in medicine
Published: July 21, 2025
Diagnostic and Therapeutic Value of the Exercise-Induced Myokine Irisin in Cancer Biology: A Comprehensive Review.
Journal: Diseases (Basel, Switzerland)
Published: July 18, 2025
Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets.
Journal: Discover oncology
Published: January 21, 2025
Key Disease-Related Genes and Immune Cell Infiltration Landscape in Inflammatory Bowel Disease: A Bioinformatics Investigation.
Journal: International journal of molecular sciences
Published: July 19, 2024
Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction-associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways.
Journal: International journal of experimental pathology
Published: July 12, 2024
A Quest for Potential Role of Vitamin D in Type II Diabetes Mellitus Induced Diabetic Kidney Disease.
Journal: Current pharmaceutical design
Published: December 01, 2023
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.
Journal: International journal of molecular sciences
Published: November 16, 2023
Relationship of Vitamin-D Deficiency with Kidney Disease in Patients with Type-2 Diabetes Mellitus (T2DM) in the Makkah Region: A Cross-Sectional Study.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: November 07, 2023
Last Updated: 09/26/2026